
    
      This is an open label, single-visit study to evaluate the relationship between mGFR and eGFR
      based either on serum creatinine (eGFRcreat) or cystatin C (eGFRcys) approximately 90 days
      following cardiac surgery. No investigational study drug will be administered.
    
  